12
ANNUAL REPORT 2013-2014
In the able hands of Andy Gray as chairman, the BPP
has facilitated cooperation between its different
sections, and the merger of the Laboratory and
Medicines Control Section with the Industrial
Pharmacy Section was finalised.
I look forward to working with all FIP officers to take
on the challenge of steering the BPP towards the
future described in the 2020 Vision.
Ema Paulino
Professional secretary
Healthcare systems are struggling throughout the world. While developing countries strive to provide universal healthcare, most developed countries are dealing with unsustainable rising costs, uneven access to services and faltering quality of care.
The adequate use of resources is fundamental to
ensuring that systems are capable of responding to
changing healthcare needs. And this includes
guaranteeing that medicines are used responsibly.
The Board of Pharmaceutical Practice (BPP), through
its eight sections, is devoted to advancing pharma-
ceutical practice in all fields. In the past year, special
emphasis has been given to discussing how ethics
and professional autonomy can safeguard individual
patient interest, and how remuneration systems can
expedite pharmacists contributions to positive
clinical and economic outcomes.
Responsible use of medicines can best be achieved
through constructive collaboration between all
stakeholders. Therefore, the BPP has continued to
invest in building a strong partnership with the Board
of Pharmaceutical Sciences, as well as with the FIP
Education Initiative. Guaranteeing that pharmaceu-
tical scientists, pharmacists and educators are
aligned in their objectives and strategies is vital to
ensuring success. This has been achieved through
combined congress programming, as well as through
a joint working group on pharmaceuticals and the
environment.
FOCUS ON AUTONOMY, REMUNERATION AND COLLABORATION
NOTES FROM THE BOARD OF PHARMACEUTICAL PRACTICE